{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:08:37Z","timestamp":1785434917035,"version":"3.56.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471849"],"award-info":[{"award-number":["82471849"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Shaanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2023-JC-QN-0918"],"award-info":[{"award-number":["2023-JC-QN-0918"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Shaanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2025JC-YBQN-1073"],"award-info":[{"award-number":["2025JC-YBQN-1073"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.molimm.2025.12.007","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T20:29:32Z","timestamp":1765916972000},"page":"142-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The role of miR-3188-mediated transcriptional activation of IL-7R\u03b1 in tumor immunotherapy research"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5341-4157","authenticated-orcid":false,"given":"Dan","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanfan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.molimm.2025.12.007_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062927","article-title":"The Interaction of Human and Epstein-Barr Virus miRNAs with Multiple Sclerosis Risk Loci","volume":"22","author":"Afrasiabi","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.molimm.2025.12.007_bib2","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired","volume":"114","author":"Ahmadzadeh","year":"2009","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.molimm.2025.12.007_bib3","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41590-019-0479-x","article-title":"Flip the coin: IL-7 and IL-7R in health and disease","volume":"20","author":"Barata","year":"2019","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2025.12.007_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"S11","key":"10.1016\/j.molimm.2025.12.007_bib5","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/cncr.30491","article-title":"Adoptive T cell therapy: An overview of obstacles and opportunities","volume":"123","author":"Baruch","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.molimm.2025.12.007_bib6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3324\/haematol.2017.167486","article-title":"Modeling multiple myeloma-bone marrow interactions and response to drugs in a 3D surrogate microenvironment","volume":"103","author":"Belloni","year":"2018","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.molimm.2025.12.007_bib7","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.ymthe.2025.04.004","article-title":"Gene regulation technologies for gene and cell therapy","volume":"33","author":"Butterfield","year":"2025","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.molimm.2025.12.007_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10549-009-0573-0","article-title":"IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo","volume":"122","author":"Cha","year":"2010","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"10.1016\/j.molimm.2025.12.007_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2025.12.007_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109092","article-title":"Decrease in CD8(+)CD45(+)CCR7(+)CD62L(+) T cells in individuals vaccinated with Sinovac-CoronaVac following COVID-19 infection","volume":"242","author":"Fonseca","year":"2022","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2025.12.007_bib11","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.3390\/ijms160510267","article-title":"Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy","volume":"16","author":"Gao","year":"2015","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.molimm.2025.12.007_bib12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00262-021-03015-1","article-title":"Transcriptomic signatures of tumors undergoing T cell attack","volume":"71","author":"Gokuldass","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"issue":"7528","key":"10.1016\/j.molimm.2025.12.007_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature13988","article-title":"Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens","volume":"515","author":"Gubin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2025.12.007_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40425-016-0164-7","article-title":"Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors","volume":"4","author":"Hall","year":"2016","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.molimm.2025.12.007_bib15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/imr.12132","article-title":"Exploiting the curative potential of adoptive T-cell therapy for cancer","volume":"257","author":"Hinrichs","year":"2014","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.molimm.2025.12.007_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.molimm.2025.12.007_bib17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1158\/2326-6066.CIR-22-0040","article-title":"Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors","volume":"10","author":"Kim","year":"2022","journal-title":"Cancer Immunol. Res"},{"issue":"46","key":"10.1016\/j.molimm.2025.12.007_bib18","doi-asserted-by":"crossref","first-page":"17337","DOI":"10.1073\/pnas.0607015103","article-title":"Small dsRNAs induce transcriptional activation in human cells","volume":"103","author":"Li","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"W1","key":"10.1016\/j.molimm.2025.12.007_bib19","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"10.1016\/j.molimm.2025.12.007_bib20","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","article-title":"GSCALite: a web server for gene set cancer analysis","volume":"34","author":"Liu","year":"2018","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.molimm.2025.12.007_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"16","key":"10.1016\/j.molimm.2025.12.007_bib22","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/j.cell.2022.06.018","article-title":"Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy","volume":"185","author":"Luoma","year":"2022","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.molimm.2025.12.007_bib23","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nri2970","article-title":"Harnessing the biology of IL-7 for therapeutic application","volume":"11","author":"Mackall","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2025.12.007_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006290","article-title":"Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies","volume":"11","author":"Magr\u00e9","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"9","key":"10.1016\/j.molimm.2025.12.007_bib25","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1261\/rna.130506","article-title":"MicroRNA promoter element discovery in Arabidopsis","volume":"12","author":"Megraw","year":"2006","journal-title":"Rna"},{"issue":"526","key":"10.1016\/j.molimm.2025.12.007_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax7992","article-title":"Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade","volume":"12","author":"Nakao","year":"2020","journal-title":"Sci. Transl. Med"},{"issue":"2","key":"10.1016\/j.molimm.2025.12.007_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/cmi.2008.10","article-title":"Interleukin-7 receptor signaling network: an integrated systems perspective","volume":"5","author":"Palmer","year":"2008","journal-title":"Cell Mol. Immunol."},{"issue":"6","key":"10.1016\/j.molimm.2025.12.007_bib28","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","article-title":"Dynamic CD8(+) T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes","volume":"186","author":"Rahim","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2025.12.007_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.iotech.2019.09.003","article-title":"Adoptive cell therapy with tumour-infiltrating lymphocytes: the emerging importance of clonal neoantigen targets for next-generation products in non-small cell lung cancer","volume":"3","author":"Robertson","year":"2019","journal-title":"Immunooncol Technol."},{"issue":"3","key":"10.1016\/j.molimm.2025.12.007_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.cji.0000210386.55951.c2","article-title":"IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells","volume":"29","author":"Rosenberg","year":"2006","journal-title":"J. Immunother."},{"issue":"4","key":"10.1016\/j.molimm.2025.12.007_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: a clinical path to effective cancer immunotherapy","volume":"8","author":"Rosenberg","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.molimm.2025.12.007_bib32","doi-asserted-by":"crossref","first-page":"3530148","DOI":"10.1155\/2018\/3530148","article-title":"Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients","volume":"2018","author":"Saint-Jean","year":"2018","journal-title":"J. Immunol. Res"},{"issue":"1","key":"10.1016\/j.molimm.2025.12.007_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41591-018-0266-5","article-title":"Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers","volume":"25","author":"Scheper","year":"2019","journal-title":"Nat. Med"},{"issue":"5","key":"10.1016\/j.molimm.2025.12.007_bib34","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/80868","article-title":"Interleukin-7 mediates the homeostasis of na\u00efve and memory CD8 T cells in vivo","volume":"1","author":"Schluns","year":"2000","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2025.12.007_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.mocell.2024.100175","article-title":"Tumor cells ectopically expressing the membrane-bound form of IL-7 develop an antitumor immune response efficiently in a colon carcinoma model","volume":"48","author":"Shin","year":"2025","journal-title":"Mol. Cells"},{"issue":"6","key":"10.1016\/j.molimm.2025.12.007_bib36","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s10147-010-0131-0","article-title":"Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management","volume":"15","author":"Shirabe","year":"2010","journal-title":"Int J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.molimm.2025.12.007_bib37","first-page":"83","article-title":"MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions","volume":"3","author":"Shukla","year":"2011","journal-title":"Mol. Cell Pharm."},{"key":"10.1016\/j.molimm.2025.12.007_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733317","article-title":"High-Throughput 3D In Vitro Tumor Vasculature Model for Real-Time Monitoring of Immune Cell Infiltration and Cytotoxicity","volume":"12","author":"Song","year":"2021","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2025.12.007_bib39","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/1078-0432.CCR-09-1303","article-title":"Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy","volume":"16","author":"Sport\u00e8s","year":"2010","journal-title":"Clin. Cancer Res"},{"issue":"21","key":"10.1016\/j.molimm.2025.12.007_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26216530","article-title":"RNA Activation-A Novel Approach to Therapeutically Upregulate Gene Transcription","volume":"26","author":"Tan","year":"2021","journal-title":"Molecules"},{"issue":"W1","key":"10.1016\/j.molimm.2025.12.007_bib41","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.molimm.2025.12.007_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/jpet.122.001234","article-title":"RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies","volume":"384","author":"Traber","year":"2023","journal-title":"J. Pharm. Exp. Ther."},{"issue":"6352","key":"10.1016\/j.molimm.2025.12.007_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan2507","article-title":"A pathology atlas of the human cancer transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.molimm.2025.12.007_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"issue":"5858","key":"10.1016\/j.molimm.2025.12.007_bib45","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1126\/science.1149460","article-title":"Switching from repression to activation: microRNAs can up-regulate translation","volume":"318","author":"Vasudevan","year":"2007","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.molimm.2025.12.007_bib46","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/mt.2009.34","article-title":"Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7","volume":"17","author":"Vera","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.molimm.2025.12.007_bib47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.coi.2016.01.004","article-title":"Adoptive cell therapy: a highly successful individualized therapy for melanoma with great potential for other malignancies","volume":"39","author":"Verdegaal","year":"2016","journal-title":"Curr. Opin. Immunol."},{"issue":"4","key":"10.1016\/j.molimm.2025.12.007_bib48","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.181.4.1519","article-title":"Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine","volume":"181","author":"von Freeden-Jeffry","year":"1995","journal-title":"J. Exp. Med"},{"issue":"7","key":"10.1016\/j.molimm.2025.12.007_bib49","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1002\/ijc.22854","article-title":"Reduced numbers of IL-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer","volume":"121","author":"Vudattu","year":"2007","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.molimm.2025.12.007_bib50","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3389\/fphar.2018.01362","article-title":"MiR-3188 Inhibits Non-small Cell Lung Cancer Cell Proliferation Through FOXO1-Mediated mTOR-p-PI3K\/AKT-c-JUN Signaling Pathway","volume":"9","author":"Wang","year":"2018","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.molimm.2025.12.007_bib51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13046-019-1144-9","article-title":"Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"10","key":"10.1016\/j.molimm.2025.12.007_bib52","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1080\/15476286.2015.1112487","article-title":"MicroRNAs activate gene transcription epigenetically as an enhancer trigger","volume":"14","author":"Xiao","year":"2017","journal-title":"RNA Biol."},{"issue":"17","key":"10.1016\/j.molimm.2025.12.007_bib53","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2217\/bmm-2020-0685","article-title":"MiR-3188 regulates the proliferation and apoptosis of hepatocellular carcinoma cells by targeting CXCL14","volume":"15","author":"Xu","year":"2021","journal-title":"Biomark. Med"},{"key":"10.1016\/j.molimm.2025.12.007_bib54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-4690-11-23","article-title":"A novel HIV-1-encoded microRNA enhances its viral replication by targeting the TATA box region","volume":"11","author":"Zhang","year":"2014","journal-title":"Retrovirology"},{"issue":"12","key":"10.1016\/j.molimm.2025.12.007_bib55","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1261\/rna.045633.114","article-title":"Cellular microRNAs up-regulate transcription via interaction with promoter TATA-box motifs","volume":"20","author":"Zhang","year":"2014","journal-title":"Rna"},{"key":"10.1016\/j.molimm.2025.12.007_bib56","first-page":"25341","article-title":"HIV-1 Infection-Induced Suppression of the Let-7i\/IL-2 Axis Contributes to CD4(+)","volume":"6","author":"Zhang","year":"2016","journal-title":"T Cell Death. Sci. Rep."},{"issue":"3","key":"10.1016\/j.molimm.2025.12.007_bib57","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4049\/jimmunol.1700196","article-title":"A Cellular MicroRNA Facilitates Regulatory T Lymphocyte Development by Targeting the FOXP3 Promoter TATA-Box Motif","volume":"200","author":"Zhang","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2025.12.007_bib58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-981-10-4310-9_7","article-title":"RNAa Induced by TATA Box-Targeting MicroRNAs","volume":"983","author":"Zhang","year":"2017","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.molimm.2025.12.007_bib59","doi-asserted-by":"crossref","first-page":"11309","DOI":"10.1038\/ncomms11309","article-title":"miR-3188 regulates nasopharyngeal carcinoma proliferation and chemosensitivity through a FOXO1-modulated positive feedback loop with mTOR-p-PI3K\/AKT-c-JUN","volume":"7","author":"Zhao","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.molimm.2025.12.007_bib60","first-page":"83","article-title":"miR-3188 Regulates proliferation and apoptosis of granulosa cells by targeting KCNA5 in the polycystic ovary syndrome","volume":"68","author":"Zhou","year":"2021","journal-title":"Acta Biochim Pol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025002901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589025002901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:54:12Z","timestamp":1777492452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589025002901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":60,"alternative-id":["S0161589025002901"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2025.12.007","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of miR-3188-mediated transcriptional activation of IL-7R\u03b1 in tumor immunotherapy research","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2025.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}